Hwatsing Technology (688120)
Search documents
华海清科抢抓窗口期拟5亿急扩产 超10%营收投入研发净利3年增4倍
Chang Jiang Shang Bao· 2025-06-30 00:22
Core Viewpoint - Huahai Qingke, a leading domestic semiconductor CMP equipment manufacturer, plans to expand its wafer regeneration capacity to seize the opportunity presented by the accelerated expansion of wafer fabs [2][3][4]. Expansion Plans - The company intends to build a wafer regeneration expansion project in Kunshan, Jiangsu, with a total planned capacity of 400,000 wafers per month, and an initial capacity of 200,000 wafers per month, with an investment of no more than 500 million yuan [3][4]. - The construction period for this project is expected to be no more than 18 months [4]. Market Position and Strategy - Huahai Qingke aims to increase its market share in wafer regeneration services, leveraging its competitive edge in advanced process wafer regeneration services and has secured orders from several large key customers [2][5]. - The company has become the largest CMP equipment manufacturer in China and the only one to achieve mass production of 12-inch CMP equipment, holding a 46.7% market share in the 12-inch CMP market as of 2023 [7]. Financial Performance - The company has shown rapid growth in operating performance, with revenue and net profit increasing significantly over the past four years. In 2021, the net profit was 198 million yuan, and it is projected to exceed 1 billion yuan by 2024, representing a growth of over four times [2][12][13]. - Revenue figures for 2022 to 2024 are 1.649 billion yuan, 2.508 billion yuan, and 3.406 billion yuan, reflecting year-on-year growth rates of 104.86%, 52.11%, and 35.81% respectively [12]. R&D Investment - The company invests over 10% of its annual revenue in R&D, with investments from 2021 to 2024 amounting to 119 million yuan, 217 million yuan, 304 million yuan, and 394 million yuan respectively [8][9]. - As of the end of 2024, Huahai Qingke has developed 17 core technologies, with 14 from independent research and development [10]. Synergy and Competitive Advantage - The wafer regeneration business is synergistic with the company's existing equipment business, enhancing customer loyalty and overall competitiveness [6][14]. - The company has achieved significant cost advantages in wafer regeneration by utilizing customized equipment, which reduces capital investment [5].
华海清科股份有限公司关于投资建设晶圆再生扩产项目的自愿性披露公告
Shang Hai Zheng Quan Bao· 2025-06-27 21:19
Project Overview - The project is named "Hua Hai Qing Ke Wafer Recycling Expansion Project" with a planned total capacity expansion of 400,000 wafers per month, where the initial construction capacity will be 200,000 wafers per month [5][6] - The initial investment is expected to not exceed 500 million RMB, with the final investment amount to be determined based on actual expenditures [5][8] - The funding will come from the company's own and self-raised funds [2][8] Project Implementation - The project will be implemented by a newly established wholly-owned subsidiary of the company [7][9] - The construction period is expected to be no more than 18 months, subject to actual progress [3][9] - The investment does not require approval from the board of directors or shareholders as it does not meet the threshold for such review [3][15] Market Context and Strategic Importance - The project aims to capitalize on the accelerated expansion of wafer manufacturing, enhancing the company's first-mover advantage and scale effect [5][15] - The integrated circuit industry is supported by national policies aimed at boosting innovation and international competitiveness, creating a favorable environment for project implementation [9] - The company has established a strong market position in wafer recycling, currently achieving a production capacity of approximately 200,000 wafers per month and receiving stable orders from major production lines [10][11] Technical and Operational Advantages - The company utilizes advanced Chemical Mechanical Polishing (CMP) and cleaning technologies, which are critical in the wafer recycling process, enhancing the competitiveness in advanced process wafer recycling services [11][12] - The existing customer base overlaps significantly with the integrated circuit manufacturing sector, providing a solid foundation for market expansion in wafer recycling [12] Impact on Company Performance - The expansion project is expected to enhance the company's production capacity and market share in wafer recycling, ultimately benefiting shareholders and improving overall company performance [15]
华海清科不超5亿投建晶圆再生扩产项目 扩大先发优势和规模效应
Zheng Quan Shi Bao Wang· 2025-06-27 12:00
Core Viewpoint - Huahai Qingsi plans to expand its wafer regeneration capacity by constructing a new project in Kunshan, Jiangsu, with a total planned capacity of 400,000 pieces per month, aiming to seize the opportunity of accelerated expansion in wafer factories [2] Group 1: Investment and Expansion Plans - The company intends to invest no more than 500 million yuan in the first phase of the expansion, which will have a capacity of 200,000 pieces per month [2] - The funding for the project will come from the company's own and self-raised funds, with a construction period expected to be no more than 18 months [2] Group 2: Financial Performance - For 2024, the company anticipates a revenue growth of 35.82% year-on-year, reaching 3.406 billion yuan, and a net profit growth of 41.4%, amounting to 1.023 billion yuan [2] - The company's net profit excluding non-recurring items is expected to grow by 40.79% to 856 million yuan [2] Group 3: Industry Context and Demand - The integrated circuit industry is a strategic sector for national economic and social development, supported by a series of government policies aimed at enhancing innovation capabilities and international competitiveness [2] - The demand for wafer regeneration is increasing due to the accelerated expansion of domestic 12-inch wafer factories, which require higher processing standards for new production lines [3] Group 4: Technological Advantages - The company has established itself as a professional foundry for wafer regeneration, leveraging its proprietary chemical mechanical polishing (CMP) and cleaning equipment to meet downstream customer needs [3] - The wafer regeneration process involves multiple steps, including film removal, coarse polishing, fine polishing, cleaning, and inspection, with CMP and cleaning technologies being core to this process [3][4] Group 5: Customer Relationships and Market Synergy - The company's customer base for wafer regeneration primarily consists of integrated circuit manufacturers, which overlaps significantly with its existing equipment business [4] - Strong cooperation with domestic integrated circuit manufacturers and recognition of the company's equipment products provide a solid foundation for expanding the wafer regeneration business [4]
华海清科(688120) - 关于投资建设晶圆再生扩产项目的自愿性披露公告
2025-06-27 09:45
证券代码:688120 证券简称:华海清科 公告编号:2025-045 华海清科股份有限公司 关于投资建设晶圆再生扩产项目的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 新建项目名称:华海清科晶圆再生扩产项目(以下简称"本项目")。 投资规模及金额:本项目规划扩建总产能为 40 万片/月,其中首期建设 产能为 20 万片/月,首期投资预计不超过 5 亿元人民币,最终投资总额以实际投 资为准,华海清科股份有限公司(以下简称"公司")将根据项目进展情况按需 投入。 资金来源:公司的自有和自筹资金。 本项目建设周期预计不超过 18 个月,最终以实际开展情况为准。 此次投资金额未达到提交董事会或股东大会审议标准,无需提交董事会 或股东大会审议,公司将按照《公司章程》相关要求履行内部审批流程。 本次投资不构成关联交易,亦不构成重大资产重组。 相关风险提示: 1、晶圆再生需求受下游半导体厂商稼动率影响较大,如果未来宏观经济发 生剧烈波动,导致计算机、消费电子、网络通信、汽车电子、物联网等终端市场 需求 ...
华海清科:拟投资不超过5亿元建设晶圆再生扩产项目
news flash· 2025-06-27 09:25
Core Viewpoint - Huahai Qingsi plans to invest no more than 500 million RMB in the construction of a wafer recycling expansion project in Kunshan, Jiangsu Province, with a total planned capacity of 400,000 pieces per month [1] Group 1 - The project will initially have a construction capacity of 200,000 pieces per month [1] - The expected investment for the first phase is no more than 500 million RMB [1] - The funding for the project will come from the company's own and self-raised funds, with a construction period expected to be no more than 18 months [1] Group 2 - The investment amount does not meet the standards for submission to the board of directors or shareholders' meeting for review [1] - The project does not constitute a related party transaction or a major asset restructuring [1]
华海清科(688120) - 国泰海通证券股份有限公司关于华海清科股份有限公司差异化分红送转特殊除权除息事项的核查意见
2025-06-25 10:32
国泰海通证券股份有限公司 关于华海清科股份有限公司 差异化分红送转特殊除权除息事项的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构")作为 华海清科股份有限公司(以下简称"华海清科"或"公司")首次公开发行股票 并在科创板上市的持续督导机构,根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定,对公司差异化分红送转特殊除权除息事项进行 了核查,具体情况如下: 一、差异化分红送转说明 公司于 2024 年 3 月 4 日和 2024 年 3 月 25 日分别召开了第二届董事会第二 次会议和 2024 年第三次临时股东大会,审议通过了《关于以集中竞价交易方式 回购公司股份方案的议案》,公司通过上海证券交易所交易系统以集中竞价交易 方式已累计回购公司股份 513,031 股,本次回购方案已实施完毕。 公司于 2025 年 4 月 28 日和 2025 年 5 月 20 日分别召开第二届董事会第十三 次会议和 2024 年年度股东大会,审议通过了《关于公司<2024 年度利润分配及 资本公积金转增股本预案 ...
华海清科(688120) - 2024年年度权益分派实施公告
2025-06-25 10:30
证券代码:688120 证券简称:华海清科 公告编号:2025-044 华海清科股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 华海清科股份有限公司(以下简称"公司")存在首发战略配售股份,首 发战略配售股份已全部上市流通 | 股权登记日 | 除权(息)日 | 新增无限售条件流 | 现金红利发放日 | | --- | --- | --- | --- | | | | 通股份上市日 | | | 2025/7/2 | 2025/7/3 | 2025/7/3 | 2025/7/3 | 一、通过分配、转增股本方案的股东大会届次和日期 1. 发放年度:2024年年度 2. 分派对象: 规定,公司回购专用证券账户中的股份,不享有股东会表决权、利润分配、公积 金转增股本等权利。 3. 差异化分红送转方案: (1)本次差异化分红送转方案 根据公司 2024 年年度股东大会会议审议通过的《关于公司<2024 年度利润分 配及资本公积金转增股本预案>的议案》,公司拟以实施权益分派股权登 ...
华海清科: 关于召开2025年第二次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-06-19 09:54
证券代码:688120 证券简称:华海清科 公告编号:2025-043 华海清科股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 股东大会召开日期:2025年7月8日 (三) 投票方式:本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 至2025 年 7 月 8 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00;通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票,应按照《上海证券交易所科创板上市公司自律监管指引第 1 号 — 规范运作》 等有关规定执行。 (七) 涉及公开征集股东投票权 不涉及 二、 会议审议事项 本次股东大会审议议案及投票股东类型 投票股东类型 序号 议案名称 A 股股东 非累积投票 ...
华海清科(688120) - 国泰海通证券股份有限公司关于华海清科股份有限公司使用部分超募资金永久补充流动资金的核查意见
2025-06-19 09:31
国泰海通证券股份有限公司 关于华海清科股份有限公司 使用部分超募资金永久补充流动资金的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构")作为 华海清科股份有限公司(以下简称"华海清科"或"公司")首次公开发行股票 并在科创板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》《上市公司募集资金监管规则》等有关规定履行持续督导 职责,对华海清科本次拟使用部分超募资金永久补充流动资金事项进行了审慎核 查,具体核查情况如下: 一、募集资金基本情况 中国证券监督管理委员会(以下简称"中国证监会")于 2022 年 4 月 27 日 出具《关于同意华海清科股份有限公司首次公开发行股票注册的批复》(证监许 可[2022]890 号),公司获准向社会公开发行人民币普通股 2,666.67 万股,发行价 格为人民币 136.66 元/股,募集资金总额为 364,427.12 万元,扣除发行费用 15,436.59 万元(不含增值税)后,募集资金净额为 348,990.53 万元。 上述募集资金到位情 ...
华海清科(688120) - 关于使用部分超募资金永久补充流动资金的公告
2025-06-19 09:30
华海清科股份有限公司 关于使用部分超募资金永久补充流动资金的公告 证券代码:688120 证券简称:华海清科 公告编号:2025-042 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 华海清科股份有限公司(以下简称"公司")使用超募资金 74,000 万元 (含部分利息收入)永久补充流动资金,占超募资金总额的比例为 29.72%。 公司承诺每十二个月内累计使用超募资金永久补充流动资金的金额将不 超过超募资金总额的 30%,本次使用部分超募资金永久补充流动资金不会影响募 投项目建设的资金需求,在永久补充流动资金后的十二个月内不进行高风险投资 以及为公司控股子公司以外的对象提供财务资助。 本事项尚需提交公司股东大会审议。 公司于 2025 年 6 月 19 日召开了公司第二届董事会第十五次会议、第二届监 事会第八次会议,审议通过了《关于使用部分超募资金永久补充流动资金的议案》, 同意公司使用超募资金 74,000 万元(含部分利息收入)永久补充流动资金,占 超募资金总额的比例为 29.72%。现将具体情况公告 ...